Not applicableLooking for participantsNCT07616401
What this trial is testing
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Who this might be right for
OsteoporosisMenopause
Istituto Auxologico Italiano 42